Pharming (PHAR) Share-based Compensation (2020 - 2026)

Pharming (PHAR) has 6 years of Share-based Compensation data on file, last reported at $4.5 million in Q4 2025.

• Quarterly Share-based Compensation rose 70.64% year-over-year to $4.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.4 million (up 23.47% YoY) and the FY2025 annual result came in at $13.8 million, up 22.39% from the prior year.
• Share-based Compensation advanced to $4.5 million in Q4 2025, from $2.6 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.5 million in Q4 2025 to a low of -$3.7 million in Q3 2021.
• A 5-year average of $1.8 million and a median of $2.0 million in 2023 frame the typical range for Share-based Compensation.
• The widest YoY moves for Share-based Compensation: up 27886.73% in 2021, down 548.57% in 2021.
• Tracing PHAR's Share-based Compensation over 5 years: stood at $1.9 million in 2021, then slumped by 43.95% to $1.1 million in 2022, then surged by 209.91% to $3.3 million in 2023, then decreased by 20.3% to $2.6 million in 2024, then soared by 70.64% to $4.5 million in 2025.
• The last three Share-based Compensation figures came in at $4.5 million (Q4 2025), $2.6 million (Q4 2024), and $2.9 million (Q3 2024), per Business Quant data.